LogicBio Therapeutics, Inc.

DB:0IF Voorraadrapport

Marktkapitalisatie: €68.2m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

LogicBio Therapeutics Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Fred Chereau

Algemeen directeur

US$2.2m

Totale compensatie

Percentage CEO-salaris24.3%
Dienstverband CEO6.6yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.8yrs
Gemiddelde ambtstermijn bestuur3.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Fred Chereau's beloning veranderd ten opzichte van LogicBio Therapeutics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2022n/an/a

-US$27m

Jun 30 2022n/an/a

-US$31m

Mar 31 2022n/an/a

-US$36m

Dec 31 2021US$2mUS$543k

-US$40m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$36m

Mar 31 2021n/an/a

-US$33m

Dec 31 2020US$2mUS$479k

-US$33m

Sep 30 2020n/an/a

-US$37m

Jun 30 2020n/an/a

-US$40m

Mar 31 2020n/an/a

-US$42m

Dec 31 2019US$633kUS$510k

-US$40m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$29m

Mar 31 2019n/an/a

-US$23m

Dec 31 2018US$2mUS$411k

-US$18m

Sep 30 2018n/an/a

-US$18m

Jun 30 2018n/an/a

-US$11m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$779kUS$385k

-US$8m

Compensatie versus markt: Fred's total compensation ($USD2.23M) is above average for companies of similar size in the German market ($USD433.84K).

Compensatie versus inkomsten: Fred's compensation has increased whilst the company is unprofitable.


CEO

Fred Chereau (55 yo)

6.6yrs

Tenure

US$2,228,208

Compensatie

Mr. Frederic Chereau, M.B.A., also known as Fred, is the Chairman of the Board of Coave Therapeutics since October 2022 and has been its Independent Non-Executive Director since October 2021. He has execut...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Frederic Chereau
President6.6yrsUS$2.23mgeen gegevens
Mark Kay
Co-Founderno dataUS$156.64k0%
€ 0
Daniel Gruskin
Chief Medical Officer2.4yrsUS$1.54m0%
€ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Adi Barzel
Co-Founder8.3yrsgeen gegevensgeen gegevens
Joshua Blacher
Interim CFOless than a yeargeen gegevensgeen gegevens
Matthias Hebben
Global VP & Head of Technology Development3.6yrsgeen gegevensgeen gegevens
Mariana Nacht
Chief Scientific Officer2yrsUS$1.34mgeen gegevens
Andrea Paul
General Counsel & Corporate Secretary1.5yrsgeen gegevensgeen gegevens
Grace Lochhead
VP & Head of Human Resources1.2yrsgeen gegevensgeen gegevens
Janice Olson
Senior Vice President of Strategy & Portfolio Management1.4yrsgeen gegevensgeen gegevens
Michael Franken
Chief Business Officer1.3yrsgeen gegevensgeen gegevens

1.8yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: 0IF's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Frederic Chereau
Presidentno dataUS$2.23mgeen gegevens
Mark Kay
Co-Founder6.8yrsUS$156.64k0%
€ 0
Leszek Lisowski
Co-Founder & Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Michael Wyzga
Independent Director4.2yrsUS$87.39k0%
€ 0
Richard Moscicki
Independent Chairman of the Board4.1yrsUS$113.64k0%
€ 0
Mark Enyedy
Independent Director2.7yrsUS$82.02k0%
€ 0
Markus Grompe
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Leon Chen
Independent Director6.8yrsUS$81.14k0%
€ 0
J. Goater
Independent Director1.9yrsUS$76.77k0%
€ 0
Daphne Karydas
Independent Director1.9yrsUS$79.64k0%
€ 0
David Russell
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Susan Kahn
Independent Directorless than a yearUS$40.31kgeen gegevens

3.4yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: 0IF's board of directors are considered experienced (3.4 years average tenure).